Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy

L Li, X Li, Y Xia, Y Chu, H Zhong, J Li, P Liang… - Frontiers in …, 2020 - frontiersin.org
Continuous Renal Replacement Therapy (CRRT) is more and more widely used in patients
for various indications recent years. It is still intricate for clinicians to decide a suitable …

What's new in multidrug-resistant pathogens in the ICU?

G Zilahi, A Artigas, I Martin-Loeches - Annals of intensive care, 2016 - Springer
Over the last several decades, antibacterial drug use has become widespread with their
misuse being an ever-increasing phenomenon. Consequently, antibacterial drugs have …

Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?

IK Delattre, FS Taccone, F Jacobs, M Hites… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The pharmacokinetic/pharmacodynamic index determining β-lactam activity is
the percentage of the dosing interval (% T) during which their free serum concentration …

Antimicrobial dose reduction in continuous renal replacement therapy: myth or real need? A practical approach for guiding dose optimization of novel antibiotics

M Gatti, F Pea - Clinical Pharmacokinetics, 2021 - Springer
Acute kidney injury represents a common complication in critically ill patients affected by
septic shock and in many cases continuous renal replacement therapy (CRRT) may be …

Antimicrobial exposure in critically ill patients with sepsis-associated multi-organ dysfunction requiring extracorporeal organ support: a narrative review

SL Cutuli, L Cascarano, P Lazzaro, ES Tanzarella… - Microorganisms, 2023 - mdpi.com
Sepsis is a leading cause of disability and mortality worldwide. The pathophysiology of
sepsis relies on the maladaptive host response to pathogens that fosters unbalanced organ …

Piperacillin-tazobactam in intensive care units: a review of population pharmacokinetic analyses

I El-Haffaf, JA Caissy, A Marsot - Clinical pharmacokinetics, 2021 - Springer
Piperacillin-tazobactam is a potent β-lactam/β-lactamase inhibitor antibiotic commonly
prescribed in the intensive care unit setting. Admitted patients often show large variability in …

Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy

S Kanji, C Roger, FS Taccone… - … : The Journal of Human …, 2023 - Wiley Online Library
Critically ill patients with sepsis admitted to the intensive care unit (ICU) often present with or
develop renal dysfunction requiring renal replacement therapy (RRT) in addition to …

Piperacillin–tazobactam as alternative to carbapenems for ICU patients

B Pilmis, V Jullien, A Tabah, JR Zahar… - Annals of Intensive …, 2017 - Springer
Several studies suggest that alternatives to carbapenems, and particulary beta-lactam/beta-
lactamase inhibitor combinations, can be used for therapy of extended-spectrum beta …

Population pharmacokinetics of piperacillin and tazobactam in critically ill patients receiving extracorporeal membrane oxygenation: an ASAP ECMO study

V Cheng, MH Abdul-Aziz, F Burrows… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
Our study aimed to describe the population pharmacokinetics (PK) of piperacillin and
tazobactam in patients on extracorporeal membrane oxygenation (ECMO), with and without …

Delivering precision antimicrobial therapy through closed-loop control systems

TM Rawson, D O'Hare, P Herrero… - Journal of …, 2018 - academic.oup.com
Sub-optimal exposure to antimicrobial therapy is associated with poor patient outcomes and
the development of antimicrobial resistance. Mechanisms for optimizing the concentration of …